ABSTRACT
This chapter addresses the relevant issues in pharmaceutical particulate science. Particulate science for pharmaceutical systems is taught in engineering and pharmacy schools on an ad hoc basis. The pharmaceutical reality is that in 90 percent of all medicines, the active ingredient is in the form of solid particles. Custom and practice in the pharmaceutical industry is such that particulate systems at best are poorly described and often are inadequately described to an extent that impacts the quality of the final product. The pharmaceutical industry has an incomplete understanding of particulate science. Using tools that are not fully appreciated or understood may confuse or mislead the scientist or regulator. Particulate science for pharmaceutical systems is taught in engineering and pharmacy schools on an ad hoc basis. The chapter also presents an overview of the key concepts discussed in this book.
